Alanine for Proline Substitution in the Peroxisome Proliferator–Activated Receptor Gamma-2 (PPARG2) Gene and the Risk of Incident Myocardial Infarction
Paul M. Ridker(Herlev Hospital), Robert Y.L. Zee(Brigham and Women's Hospital), Jorge Plutzky(Brigham and Women's Hospital), Klaus Lindpaintner(Roche (Switzerland)), Nancy R. Cook(Brigham and Women's Hospital), Suzanne Cheng(Roche (Switzerland))
Cited by 101
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
|New England Journal of Medicine|2023|2.6k